ZNF226 Inhibitors
ZNF226 inhibitors encompass a range of compounds that indirectly influence the functional activity of ZNF226, a zinc finger protein involved in DNA binding and gene regulation. These compounds usually target pathways or molecular processes that ZNF226 is likely to interact with, either by regulating gene expression or by protein-protein interactions. For example, Triptolide and Curcumin are compounds that inhibit NF-κB, a transcription factor that regulates a wide array of genes. Given that ZNF226 functions as a gene regulator, the inhibition of NF-κB by these compounds could result in reduced expression of genes that are co-regulated by ZNF226, thereby indirectly decreasing ZNF226's functional activity.
In addition to NF-κB inhibitors, proteasome inhibitors like Bortezomib and MG132 could also impact ZNF226 function. These inhibitors can prevent the degradation of IκB, leading to the inhibition of NF-κB and potentially altering the transcriptional landscape in which ZNF226 operates. Similarly, compounds that modulate chromatin structure and gene expression, such as JQ1 and Vorinostat, may affect the ability of ZNF226 to access and bind DNA, hence indirectly inhibiting its role in gene regulation. JQ1's suppression of BET proteins could reduce the expression of oncogenes or other genes that might be co-regulated by ZNF226, while Vorinostat's HDAC inhibitory activity could disrupt ZNF226's interaction with chromatin by altering histone acetylation patterns.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide is a diterpene triepoxide that inhibits the transcription factor NF-κB. ZNF226 regulates gene expression through DNA binding. Triptolide's inhibition of NF-κB can reduce the expression of genes that ZNF226 may regulate or co-regulate, leading to a decrease in ZNF226's functional activity. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor that can prevent the degradation of IκB, an inhibitor of NF-κB. By stabilizing IκB, bortezomib indirectly inhibits NF-κB, potentially diminishing the transcription of genes under ZNF226's control. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 is a BET bromodomain inhibitor that can suppress the expression of certain oncogenes. By inhibiting the BET proteins, JQ1 may downregulate genes that are indirectly regulated by ZNF226 through chromatin remodeling. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that can lead to the accumulation of regulatory proteins, including those involved in the ubiquitin-proteasome pathway. ZNF226's function could be indirectly inhibited by the alteration of proteasome-mediated degradation of proteins that interact with ZNF226. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor. By reducing DNA methylation, it can lead to the reactivation of genes that are silenced by methylation. This could lead to the expression of genes that negatively regulate ZNF226's function. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat is an HDAC inhibitor that leads to increased acetylation of histones, affecting gene expression. This can potentially disrupt the interaction of ZNF226 with chromatin, leading to decreased ZNF226-mediated gene regulation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that can suppress cell growth and proliferation. By inhibiting mTOR, Rapamycin may decrease the expression of genes involved in cell cycle regulation that could be under ZNF226's control. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that leads to the downregulation of Akt signaling. As ZNF226 might interact with target genes affected by Akt signaling, its functional activity could be indirectly inhibited by LY294002. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an MEK inhibitor that impairs the MAPK/ERK pathway. Given that ZNF226 could regulate genes downstream of this pathway, the inhibition of MAPK/ERK signaling by PD98059 can indirectly decrease ZNF226's regulatory functions. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin is a compound that can suppress NF-κB activation and influence histone acetylation. Its action on NF-κB can lead to a decrease in gene expression that ZNF226 might regulate, thus indirectly inhibiting ZNF226's functional activity. | ||||||